Dr. Michel Bourin is currently serving as a psychiatrist in handicapped adults in Montredon(near Narbonne). He served as Professor of Pharmacology at the University of Nantes, Nantes, France, where he has been Head of Research in the Neurobiology of anxiety and depression from 1985 to 2009. He also served as a WHO expert for drug dependence (2000-2016). He was also an adjunct professor of the Department of Psychiatry at Edmonton University in Alberta, Canada, and is still a visiting professor at the University of Craiova in Romania, Dr. Bourin has published more than 350 original articles in the field of psychopharmacology and psychiatry, and more than 200 educational/review articles or book chapters, in both English and French. He published and wrote 12 books in French.

Dr. Mirjana Čolović is a graduate engineer of technology for biochemical engineering and biotechnology and a Ph.D. in chemistry and chemical technology (the University of Belgrade, Faculty of Technology and Metallurgy, Serbia). Since 2005 she has been employed at University of Belgrade, “Vinča” Institute of Nuclear Sciences, Department of Physical Chemistry, Serbia (current position-senior research associate). Dr. Mirjana Čolović's research activities have been taking place in the field of enzymology, medical and bioinorganic chemistry, and toxicology. Her PhD thesis was directed to the development of batch and flow cholinesterase based systems for insecticide detection and neurotoxicity evaluation and to in vitro evaluation of non-specific toxic effects of insecticides by monitoring prooxidative and cyto/genotoxic properties. In 2008, she started investigation on pharmacological properties of (newly) synthesized metal-based compounds for the purpose of new drug development, which includes interactions between the biologically active compounds and enzyme targets (cholinesterases, ATPases) in cancer and neurological diseases, in vitro prooxidative, cyto- and genotoxic effects on various isolated human and animal model cells, and in vivo antidiabetic properties and toxicity evaluation by monitoring various biomarkers of nephron- and hepatotoxicity. Mirjana Čolović's scientific outcome involves more than 100 scientific contributions - ˃40 papers in impacted international journals, 4 chapters in books, https://orcid.org/0000-0001-5037-9985, Scopus ID: 23566649100. She has been engaged as a participant/leader in 2 national and 5 international scientific projects, and as a referee in ˃20 international journals and 9 foreign projects. Her citation score is more than 1300 (Scopus). Furthermore, she has been an associate editorial board member (Current Medicinal Chemistry, Mini-Reviews in Medicinal Chemistry), an editorial board member (International Journal of Bioorganic Chemistry), a scientific committee member (3 conferences/workshops), an organizing committee member (1 workshop), and a management committee member/participant (4 COST actions).

Prof. Dr. Danijela Krstić obtained her BSc. MSc. and Ph.D. in biochemistry from the Faculty of Chemistry, University of Belgrade, Serbia. Works as a Full Professor of Medical Chemistry at Faculty of Medicine, University of Belgrade. The main fields of her research activities are 1) Enzymology: enzyme inhibition and kinetics; 2) Toxicology: in vitro and in vivo toxicity evaluation of newly synthesized and standard pharmacologically and physiologically active compounds, toxicity biomarkers: cytotoxicity and genotoxicity assays, oxidative stress parameters, biochemical markers of neuro-, nephro- and hepatotoxicity; and 3) Medicinal chemistry: interactions between the target enzymes and biologically active molecules (drugs, novel potential drugs, metal-based compounds, pesticides). She published more than 50 scientific papers in impacted international journals and her citation score is higher than 1500 (Scopus), https://orcid.org/0000-0002-9192-8087; Scopus Author ID: 57199836500. Dr. Danijela Krstić has been engaged as a leader/participant in 4 national and 5 international scientific projects.